Anaphylaxis in an emergency department: Epidemiology, clinical features and management

##plugins.themes.academic_pro.article.main##

Hanen Ghazali
Mouna Gammoudi
Anware Yahmadi
Ghezela Chaaebeni
Ahmed Souyah
Sami Souissi

Abstract

 Introduction: Studies report that anaphylaxis was under-diagnosed in emergency department (ED) and emergency management was often in disagreement with international recommendations.

Aim of the study: The aim of this study was to describe the epidemiology, clinical features, management and outcome of patients with anaphylaxis presenting to an ED.

Methods: Prospective, observational study over four years (June 2010 to May 2014). Inclusion criteria: patients (> 14 years of age) presenting consecutively to the ED with the diagnosis of anaphylaxis. Collection of epidemiological, clinical and therapeutic parameters

Results: During the study, 239 patients were enrolled. Mean age = 40±15 years. Sex-ratio=0.8.  History of anaphylaxis was reported in 40% of cases. Clinical features n (%): cutaneous features 229 (96), cardiovascular features 124 (52), respiratory features 127 (53), gastrointestinal features 48 (20) and neurologic features 4 (10). Most common allergens: drugs 62%, food 24% and insects 4%. No causes were apparent in 8% of cases. An anaphylactic shock was recorded in 73 patients (31%). Adrenaline was used in 83%of patients, intravenously in 31%.  Corticosteroids and histamine H1 antagonist were prescribed in 98 and 51% respectively. Biphasic reactions were reported in three patients. There was no death cases registered.

Conclusion: Our results showed that the prevalence of anaphylaxis was low.This demonstrates that anaphylaxis is a situation which remains underestimated. It is therefore imperative to conduct prospective multicenter studies in emergency services for better determination of its impact and its risk factors.

Keywords:

Anaphylaxis, Epinephrine, Immediate hypersensitivity, emergency department

##plugins.themes.academic_pro.article.details##

References

  1. Peng MM, Jick H. A population-based study of the incidence, cause, and severity of anaphylaxis in the United Kingdom. Arch Intern Med 2004;164:317-9.
  2. Sampson HA, Muñoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A et al. Second symposium on the definition and management of anaphylaxis: summary report. Ann Emerg Med 2006;47:373-80.
  3. Kanny G, Moneret-Vautrin DA, Flabbee J, Beaudouin E, Morisset M, Thevenin F. Population study of food allergy in France. J Allergy ClinImmunol 2001;108:133-40.
  4. Helbling A, Hurni T, Mueller UR, Pichler WJ. Incidence of anaphylaxis with circulatory symptoms: a study over a 3-year period comprising 940,000 inhabitants of the Swiss Canton Bern. ClinExp Allergy 2004;34:285-90.
  5. Bohlke K, Davis RL, DeStefano F, Marcy SM, Braun MM, Thompson RS et al. Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization. J Allergy ClinImmunol 2004;113:536-42.
  6. Mullins RJ. Anaphylaxis: risk factors for recurrence. ClinExp Allergy 2003;33:1033-40.
  7. Sheikh A, Alves B. Age, sex, geographical and socio-economic variations in admissions for anaphylaxis: analysis of four years of English hospital data. ClinExp Allergy 2001;31:1571-6.
  8. Wilson R. Upward trend in acute anaphylaxis continued in 1998-9. BMJ 2000;321(7267):1021.
  9. Bellou A, Manel J, Samman-Kaakaji H, de Korwin JD, Moneret-Vautrin DA, Bollaert PE et al. Spectrum of acute allergic diseases in an emergency department: an evaluation of one years' experience. Emerg Med 2003;15:341-7.
  10. Moneret-Vautrin DA, Kanny G, Morisset M, Rancé F, Fardeau MF, Beaudouin E. Severe food anaphylaxis: 107 cases registered in 2002 by the Allergy Vigilance Network. Eur Ann Allergy ClinImmunol 2004;36:46-51.
  11. Stewart AG, Ewan PW. The incidence, aetiology and management of anaphylaxis presenting to an accident and emergency department. QJM 1996;89:859-64.
  12. Brown AF, McKinnon D, Chu K. Emergency department anaphylaxis: A review of 142 patients in a single year. J Allergy ClinImmunol. 2001;108(5):861-6.
  13. Pastorello EA, Rivolta F, Bianchi M, Mauro M, Pravettoni V. Incidence of anaphylaxis in the emergency department of a general hospital in Milan. J Chromatogr B Biomed Sci App 2001;756:11-7.
  14. Gaeta TJ, Clark S, Pelletier AJ, Camargo CA. National study of US emergency department visits for acute allergic reactions, 1993 to 2004. Ann Allergy Asthma Immunol 2007;98:360-5.
  15. Simons FER, Ardusso LRF, Dimov V, Ebisawa M, El-Gamal YM, Lockey RF et al. World Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence base. Int Arch Allergy Immunol 2013;162:193-204.
  16. Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1977;1:466-9.
  17. Moneret-Vautrin DA, Morisset M, Flabbee J, Beaudouin E, Kanny G. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy 2005;60:443-51.
  18. Gillman A, Douglass JA. What do asthmatics have to fear from food and additive allergy? Clin ExpAllergy 2010;40:1295-302.
  19. Ben Ghezala H. Anaphylaxie: Aspects épidémiologiques, cliniques et thérapeutiques [Thèse de Doctorat en Médecine]. Tunis: Faculté de Médecine de Tunis; 2009.
  20. Clark S, Long AA, Gaeta TJ, Camargo CA. Multicenter study of emergency department visits for insect sting allergies. J Allergy ClinImmunol 2005;116:643-9.
  21. Smit DV, Cameron PA, Rainer TH. Anaphylaxis presentations to an emergency department in Hong Kong: incidence and predictors of biphasic reactions. J Emerg Med 2005;28:381-8.
  22. Thong BY, Cheng YK, Leong KP, Tang CY, Chng HH. Anaphylaxis in adults referred to a clinical immunology/allergy centre in Singapore. Singapore Med J 2005;46:529-34.
  23. Ben-Shoshan M, Clarke AE. Anaphylaxis: past, present and future. Allergy 2011;66:1-14.
  24. Yun J, Katelaris CH. Food allergy in adolescents and adults. Intern Med J 2009;39:475-8.
  25. Bouhajja B, Souissi S, Ben Othman M, Ghazali H, Mougaida M, Chekir M. Anaphylaxie: conséquences cliniques et prise en charge thérapeutique aux urgences. Tunis Med 2009;87:246-52.
  26. Soar J, Pumphrey R, Cant A, Clarke S, Corbett A, Dawson P et al. Emergency treatment of anaphylactic reactions-guidelines for healthcare providers. Resuscitation 2008;77:157-69.
  27. Simons FER, Ardusso LRF, Bilò MB, El-Gamal YM, Ledford DK, Ring J et al. World Allergy Organization Guidelines for the Assessment and Management of Anaphylaxis. World AllergyOrgan J 2011;4:13-37.
  28. Bidat E, Tannery B, Lagardère B. Choc anaphylactique par allergie alimentaire: issue fatale malgré l'injection très précoce d'adrénaline. Arch Fr Pédiatr 1993;50:361.
  29. Bosetti M, Ispano M, Rotondo F, Ansaloni R, Ortolani C. Anaphylaxis resulting in death after inhalation of milk proteins. Allergy 1997;52suppl 37:S121.
  30. Grabenhenrich L, Hompes S, Gough H, Ruëff F, Scherer K, Pföhler C et al. Implementation of Anaphylaxis Management Guidelines: A Register-Based Study. PLoS One 2012;7(5):e35778.
  31. Decker WW, Campbell RL, Manivannan V, Luke A, St Sauver JL, Weaver A et al. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J Allergy ClinImmunol 2008;122:1161-5.
  32. Rohrer CL, Pichler WJ, Helbling A. Anaphylaxis: clinical aspects, etiology and course in 118 patients. Schweiz Med Wochenschr. 1998;128(3):53-63.
  33. Goddet NS, Templier F, Descatha A, Dolveck F, Baer M, Chauvin M et al. Fréquence et prise en charge des pathologies allergiques en réanimation pré-hospitalière. JEUR 2005;18:140-8.
  34. Chiriac A, Demoly P. Choc anaphylactique : quoi de neuf ? Rev Fr Allergol 2010;50:64-71.
  35. Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions.Clin ExpAllergy. 2000;30(8):1144-50.
  36. Dewachter P, Jouan-Hureaux V, Lartaud I, Bello G, de Talancé N, Longrois D et al. Comparison of arginine vasopressin, terlipressin, or epinephrine to correct hypotension in a model of anaphylactic shock in anesthetized brown Norway rats. Anesthesiology. 2006;104(4):734-41.
  37. Kemp SF, Lockey RF, Simons FER, World Allergy Organization ad hoc Committee on Epinephrine in Anaphylaxis. Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization. Allergy 2008;63:1061-70.
  38. Clark S, Bock SA, Gaeta TJ, Brenner BE, Cydulka RK, Camargo CA et al. Multicenter study of emergency department visits for food allergies. J Allergy ClinImmunol. 2004;113(2):347-52.
  39. Caton EJR, Flynn M. Management of anaphylaxis in the ED: A clinical audit. IntEmergNurs. 2013;21(1):64-70.
  40. Hocagil H, Karakilic E, Hocagil C, Senlikci H, Buyukcam F. Underdiagnosis of anaphylaxis in the emergency department: misdiagnosed or miscoded? Hong Kong Med J. 2013;19(5):429-33.
  41. Alrasbi M, Sheikh A. Comparison of international guidelines for the emergency medical management of anaphylaxis. Allergy. 2007;62(8):838-41.
  42. Simons FE, Gu X, Simons KJ. Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J Allergy ClinImmunol. 2001;108(5):871-3.
  43. Russell WS, Farrar JR, Nowak R, Hays DP, Schmitz N, Wood J et al. Evaluating the management of anaphylaxis in US emergency departments: Guidelines vs. practice. World J Emerg Med. 2013;4(2):98-106.
  44. Gaba DM, Howard SK, Fish KJ, Smith BE, Sowb YA. Simulation-based training in anesthesia crisis resource management (ACRM): a decade of experience. Simul Gaming. 2001;32(2):175-93.
  45. Brown SGA. Anaphylaxis: clinical concepts and research priorities. Emerg Med Australas. 2006;18(2):155-69.
  46. Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012;367:1901-11.
  47. Perel P, Roberts I, Ker K. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2012 Juin 13;6:CD000567.
  48. Lee JM, Greenes DS.Biphasic anaphylactic reactions in pediatrics.Pediatrics. 2000;106(4):762-6